Comparison of characteristics of patients with coronary heart disease receiving lipid-lowering therapy versus those not receiving such therapy

American Journal of Cardiology

Volumn 91, Issue 11, 2003, Pages 1352-1354

  Kopjar, Branko ^a   Sales, Anne E B ^b   Piñeros, Sandra L ^b   Sun, Haili ^b   Li, Yu Fang ^b   Hedeen, Ashley N ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN; STATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0038626419     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00329-1     Document Type: Article

References (2)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497.
2. Sueta C.A., Chowdhury M., Boccuzzi S.J., Smith S.C. Jr, Alexander C.M., Londhe A., et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol. 83:1999;1303-1307.